A biotech startup called Outer Biosciences is changing beauty and medical research methods. Founded by Michael Polansky, it obtains discarded human skin tissue from approved biobanks and extends its in vitro viability to one month, far longer than the usual few days. The company feeds this tissue data into a self-enhancing AI model that predicts effective new ingredients and refines predictions through repeated testing. It supplies these validated ingredients to major beauty and pharmaceutical firms via licensing. The startup is also working with drug companies to study skin rash causes linked to certain cancer treatments, using its approach to address limitations of traditional testing methods.